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Complex regional pain syndrome (CRPS) is characterised by neuropathic-type pain in a regional 
distribution with associated signs and symptoms including: swelling, change in temperature, 
change in skin colour and motor dysfunction.  Although CRPS is not a common condition, the 
disease burden is high and can lead to long-term impairment and disability.  Current guidelines 
for the management of paediatric CRPS are mostly extrapolated from adult data. Literature 
regarding treatment and long-term prognosis of paediatric CRPS is sparse and often lacks well-
defined and reproducible outcome measures.  
 
Aim 
This study aims to assess the efficacy of treatment of CRPS Type 1 in children admitted to Red 
Cross War Memorial Children’s Hospital (RCWMCH) in eliminating pain and improving function.  
 
Methods 
 A retrospective folder review and follow-up telephonic survey of all children admitted to RCWMCH 
over a 5 year period was performed. Long-term follow-up was defined as a minimum of 6 months 
after discharge from hospital. Follow-up questionnaires included the Faces Pain Scale, and the 
Paediatric Quality of Life Inventory Version 4 generic core scales (PedsQL 4.0). 
 
Results 
Nine children with confirmed CRPS Type1 were included in the study, all of whom participated in 
long-term follow-up. Children received in-hospital treatment from a multidisciplinary team, 
including intensive physiotherapy and psychological therapy. Pharmacological treatment 
consisted of an intravenous ketamine infusion and varying combinations of gabapentin, 
clonidine and amytriptilline. One child received epidural local anaesthetic infusion. On average, 
pain scores improved by 67.8% by the time of discharge.  At an average long-term follow-up 
interval of 10.3 months (ranging between 6 to 21 months), the pain score had worsened by 
10.5% compared to discharge. Two children (22.2%) experienced complete recovery while the 
remainder experienced partial recovery. Three children (33.3%) suffered a relapse, of which one 
recovered completely. At long-term follow-up, children for whom PedsQL 4.0 data was available 
from admission all demonstrated clinically meaningful improvements in all four functional 
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domains (physical, social, emotional and school). Children scored on average similar to healthy 
peers in terms of social, emotional and school function, but worse in terms of overall quality of 
life.  The area most affected was that of physical function, in which children with CRPS scored 
worse than other children with chronic health conditions.  
 
Conclusion 
Children with CRPS experience significant improvement in pain and function with an in-patient, 
multidisciplinary, non-invasive treatment approach. Most children return to a level of school 
functioning comparable to healthy peers. However, the rate of complete recovery is low, relapse 
is common, and most children have significant persistent impairment of physical function. We 
recommend a long-term support program for children with CRPS and their families, and 
standardisation of follow-up intervals and outcome measures to enable comparison between 
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Note on language and formatting of this document: 
The article ‘Multidisciplinary management of Complex Regional Pain Syndrome Type 1 in Children 
admitted to Red Cross War Memorial Hospital: A case series describing long-term effects on Pain, 
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English was used in the article section since this is an American journal. Vancouver style 
referencing is used, according to the author guidelines. Furthermore, Arial font size 10 was used, 
with double spacing, as specified by the journal. 
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CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW 
1 Objective 
The objective is to perform a critical review of the current literature on complex regional pain 
syndrome (CRPS). Particular emphasis will be placed on literature regarding CRPS in children 
including the current understanding of its pathophysiology, treatment recommendations and long-
term outcomes after treatment.  
2 Literature search strategy 
A search was conducted on Pubmed of publications from 1995-2015 using the following 
keywords: complex regional pain syndrome; children; paediatric; incidence; treatment; 
epidemiology; and pathophysiology. Research in adult and paediatric populations was reviewed 
with an emphasis on paediatric literature. Only articles in English or with a readily available English 
translation were included. 
Focus was placed on systematic reviews, randomised controlled trials, prospective studies, cohort 
studies and case series.  In areas where little information regarding paediatric CRPS was 
available, the search was extended to include adult CRPS. In adult studies, the focus was on 
systematic review articles.  
3 Introduction 
CRPS is characterised by neuropathic-type pain with significant autonomic features occurring in 
a regional distribution, usually involving one of the extremities, but it can also extend to the trunk 
(1,2).Neuropathic pain is defined by the international association of the study of pain (IASP) as 
``pain caused by a lesion or disease of the somatosensory nervous system`` (http://www.iasp-
pain.org/Taxonomy#Neuropathicpain). This differs from nociceptive pain that is defined by the 
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IASP as ``pain that arises from actual or threatened damage to non-neural tissue and is due to 
the activation of nociceptors`` (http://www.iasp-pain.org/Taxonomy#Nociceptivepain).  
The pain is disproportionate to the initiating event and is complicated by other symptoms and 
signs in the affected area, including: sensory (allodynia, hyperalgesia); vasomotor (temperature 
and/or skin colour asymmetry); sudomotor (oedema and/or sweating asymmetry); motor 
(weakness, decreased range of motion, tremor) and trophic changes (changes in hair/nail 
growth)(3).  It is most commonly  preceded by a mild to moderate injury, but in about 10% of cases 
can occur spontaneously (4). 
3.1 Diagnostic criteria 
There is no gold standard diagnostic test available therefore, CRPS is a diagnosis of exclusion, 
based on clinical criteria, and relying on physician awareness of the disorder (5). The International 
Association for the Study of Pain (IASP) has validated the Budapest Criteria for the diagnoses of 
CRPS (6,7)(Appendix A) . Although these criteria have only been validated for the adult 
population, they are currently recommended for, and used in, the paediatric population (8). 
Distinction is made in the literature between CRPS Type I (no demonstrable nerve injury) and 
Type II (nerve injury demonstrated, but symptoms extend beyond dermatome), however, signs 
and symptoms are similar and there is no evidence of differences in the pathophysiology or 
treatment outcomes of the two groups (1).   
3.2 Epidemiology 
CRPS occurs in both adults and children, although the exact incidence in both groups is unclear 
(9).  Incidence in adults is between 5.7-26 patients per 100 000 person years (10,11). In children, 
incidence is less well defined.  Some of the large paediatric pain centres treat between 1-9 cases 
per year (12).  Incidence could be higher, as milder forms of the disease may never present to 
paediatric pain centres. Although the incidence is fairly low, the impact of the disease can be 
devastating, leading to severe impairment and disability, both short- and long-term (13). 
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Increasing public and health-care worker awareness of CRPS is important in lowering the disease 
burden, since early diagnosis and initiation of treatment is associated with improved functional 
outcomes (14).  
3.3 Pathophysiology 
Current theories and evidence regarding the pathophysiology of CRPS suggest multifactorial 
mechanisms, which include: abnormalities of inflammation and immune response; central and 
peripheral nervous system sensitization; changes in somatosensory representation in the brain; 
autonomic disturbances; underlying genetic factors; local tissue hypoxia and psychophysiologic 
interactions (1,2).  
Studies investigating the pathophysiological mechanisms have mostly been performed in adults, 
and whether the same mechanisms apply in children is uncertain (8). There are some differences 
between the clinical presentation of CRPS in children and adults, which would suggest the 
possibility of a differing pathophysiology. In a review by Stanton-Hicks et al., it was concluded that 
the current evidence suggests that the pathophysiology in adults and children is most likely 
identical, although the grading of the evidence upon which this conclusion was based is unclear 
(15). 
Specific paediatric studies have investigated the hypothesis of cortical reorganisation in the 
Central Nervous System (CNS) by using functional Magnetic Resonance Imaging (fMRI).  The 
outcomes demonstrate central reorganisation in the intrinsic brain networks of children with CRPS 
during the disease state compared to healthy controls, involving the sensory and motor cortices 
as well as in the hippocampus and hypothalamus. There is additional evidence of reversal of these 
changes following 3-4 week treatment interventions (16–18). This provides a fascinating avenue 
for assessing therapeutic effects, as well as a means of investigating underlying brain changes in 




3.4 Validation of need for this research 
There is a need for more comprehensive studies in the paediatric population, but the low incidence 
leads to problems of randomisation, blinding and adequate sample size (13). Currently, most 
knowledge is based on retrospective studies and case series, which are often of poor 
methodological quality and  lack validated outcome measures, hampering comparison of 
outcomes (19).  No studies regarding paediatric CRPS in Africa could be found in the literature 
search. Pain and functional outcome after injury is influenced by socio-economic, cultural and 
environmental factors (9,20,21). It is therefore important to assess whether CRPS in South Africa, 
has similar clinical features and treatment outcomes to that reported in studies from other 
countries. Using exact reporting of treatment and reproducible and validated outcome measures 
will enable comparison with other studies 
4 Treatment 
The current recommended treatment approach for both adult and paediatric CRPS consists of 
multidisciplinary management, including, but not limited to, the domains of pharmacological 
therapy, physiotherapy, occupational therapy, psychological and family therapy and invasive 
procedures in certain circumstances (5,22–25).  
4.1 Pharmacological management 
Current recommendations of pharmacological management in paediatric CRPS are 
predominantly based on data from adult CRPS or on paediatric non-CRPS neuropathic pain 
(12,24).  Possible pharmacological treatment regimens include: simple analgesia, 
anticonvulsants, antidepressants, corticosteroids, bisphosphonate, calcitonin, free-radical 
scavengers and N-Methyl D-Aspartate (NMDA) antagonists (i.e. Ketamine, Memantine) (3,26,27). 
Multiple treatments are often used in conjunction, and dosing schedules vary or are not clearly 
reported in the literature, making it difficult to establish the effectiveness of a single treatment (27).  
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It is unclear whether anticonvulsants are indicated in the management of CRPS.  The meta-
analysis of treatment for CRPS in adults, published in 2014 by Wertli et al., reports gabapentin as 
having similar efficacy to placebo (26). Birklein et al. in a narrative review in 2015 similarly 
concluded that gabapentin may have only marginal effectiveness, which is unlikely to have clinical 
importance (28). In contrast, a more recent systematic review by Finnerup et al., (2015) 
recommends anticonvulsants, specifically pregabalin and gabapentin, as part of the first line 
treatment for neuropathic pain. However, it must be noted, that this review included studies of 
CRPS type 2, but not of CRPS type 1 (29). Despite this uncertainty in adult literature, 
anticonvulsant use is reported in various paediatric CRPS studies and case series (15,30). In the 
focused review by Katholi et al., it was concluded that anticonvulsants may be indicated in 
paediatric CRPS based on case reports of its benefit in paediatric CRPS (24). Gabapentanoids 
block  the α2δsubunit on calcium channels in the dorsal horn of the spinal cord (31). Although 
reported as having minimal side-effects and being well tolerated, the long-term safety of these 
medications and effect on the central nervous system in children remains a concern (8).  
The use of a tricyclic antidepressant (TCA), most commonly amitriptyline, is reported in various 
paediatric CRPS studies (15,17,23,30,32,33). This practice should be questioned, since Cossins 
et al., in a  systematic review in 2013, concluded that there is no evidence for the use of 
antidepressants in adult CRPS (34). In contrast, the more recent 2015 systematic review of adult 
neuropathic pain recommends antidepressants, specifically TCA and serotonin-noradrenaline 
reuptake inhibitors (SNRI) as  part of the first line treatment (29). As stated above, it has to be 
noted that this review only included studies of CRPS type 2 and not type 1. The SNRIs have not 
been widely used in the paediatric CRPS population, possibly due to less experience of its use 
relative to the TCAs. Similar concerns as with the anticonvulsants exist with regards to the long-
term safety of the use of antidepressants in children (8), and considering the lack of evidence, 
one has to question the advisability of its use in the paediatric population.  
The use of corticosteroids is based on the hypothesis of abnormal immune activation in CRPS 
(1). Corticosteroids reduce posttraumatic inflammation, oedema and swelling and may be useful 
as treatment of the acute stages of the disease(28). Direct clinical-trial evidence for its use in the 
early stages of CRPS exists and  its use is recommended  in adults with CRPS (26–28).  
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Once again, its use has not been specifically examined in paediatric CPRS and Katholi et al., 
expressed concern that appropriate clinical indicators may not have been adequately elucidated 
for its use in children (24). 
Three phase bone scans in people with CRPS often show patchy osteoporosis and osteopenia of 
the affected limb, presumably from osteoclast activation (1). The rationale for the use of 
bisphosphonate and calcitonin as treatment is based on its osteoclast inhibition properties (35). 
In their meta-analysis Wertli et al., found bisphosphonates and calcitonin to be the most effective 
in terms of pain reduction compared to other treatment modalities. Bisphosphonate is 
recommended where symptom duration has been less than 12 months and calcitonin for 
symptoms present for longer than 12 months (26,28). The use of bisphosphonate has shown 
promising results in a case report of an 11 year old girl with CRPS (36). The use of calcitonin 
(mostly in the intranasal form) as treatment in paediatric CRPS is reported (12,19), but the efficacy 
and safety of treatment in the paediatric population has not been formally investigated (24).  
The use of NMDA antagonists as treatment is based on the theory of underlying central 
sensitisation in CRPS and the effect of NMDA as a neurotransmitter. Pain relief is believed to be 
achieved via modulation of spinal cord NMDA receptors (34,37). The systematic review by 
Cossins et al., the meta-analysis by Wertli et al., and the recent Cochrane review by O’Connell et 
al., all concluded that there is low to moderate quality evidence for the use of low-dose intravenous 
(IV) ketamine in adult CRPS (26,34,38). A recent study of longitudinal intravenous subanaesthetic 
ketamine infusion in children with pain syndromes has reported it as both safe and effective 
treatment, with the greatest effect seen in CRPS (39). Despite its potential as a drug of abuse and 
its side effects at higher doses, reviews on the topic do suggest ketamine as a treatment option 
in paediatric CRPS (24,27).  
The use of free-radical scavengers is based on the underlying theory of local tissue hypoxia 
leading to cellular damage via oxygen free radicals (1,40).  Topical dimethylsulphoxide (DMSO) 
cream (50%) has shown better efficacy than placebo in improving CRPS symptoms (22,38). 
Comparable results were achieved with 50% DMSO cream and oral N-acetylcysteine, another 
free radical scavenger,  in improving CRPS symptoms (22,41). Vitamin C in high doses (500mg 
per day for 50 days) has prophylactic use in decreasing the incidence in CRPS after dorsal radius 
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fracture in adults (22,34). Tan et al., reports using free-radical scavengers as part of the standard 
treatment protocol in paediatric CRPS (4,40). Although no specific evidence for the use of free-
radical scavengers in paediatric CRPS could be found, in a focused review by  Katholi et al., it 
was concluded that Vitamin C may be indicated in paediatric CRPS (24). 
Simple analgesia, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), 
have often been neglected by patients and practitioners in the treatment of CRPS, possibly 
because of the belief that these drugs are too simple for such a complicated condition (27). There 
is however Level 4 evidence1 for the use of NSAIDS in CRPS and Level 3 evidence2 for their use 
in other neuropathic pain conditions (27). Due to good safety profiles and efficacy, its use is 
recommended as part of the multimodal treatment approach to pain management in CRPS 
(3,22,26).  
Evidence of the pathophysiological contribution of underlying vasoconstriction to CRPS has led 
to vasodilators being trialled as treatment (1,2,28,37). Tadalafil is the vasodilator that has been 
specifically studied in CRPS and the meta-analysis by Wertli et al., concluded that vasodilators 
showed better long-term pain reduction in CRPS than placebo (26). Contradicting this, the 
Cochrane review by O’Connell et al., judged that there was only very poor quality evidence that 
Tadalafil may have a short-term benefit in pain reduction but that this was unlikely to be clinically 
significant (38).  The evidence for the use of vasodilators in adults does not currently hold sufficient 
medical advantages to warrant clinical trials in children (40). 
                                                   
1 Level 4 evidence includes anecdote, case reports and clinical experience 
2 Level 3 evidence includes retrospective studies, open-label trials and pilot studies 
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4.2 Non-Pharmacological management 
4.2.1 Physiotherapy 
Physiotherapy (PT) is recommended in the literature as an essential component for the treatment 
of CRPS, in both adults and children (12,24,25,28). Functional restoration should be the focus of 
treatment and all other treatment modalities should be aimed at facilitating participation in 
rehabilitation (27). In adults, there has been low quality evidence that PT, combined with medical 
management, is more effective than occupational therapy and social work combined with medical 
management (38). However, the effectiveness of PT as stand-alone therapy has been difficult to 
establish, due to the fact that multiple treatment modalities are often employed concurrently 
(19,38,42).  
Within PT, there is a wide variety of possible treatment modalities (19). Of these, graded motor 
imagery (GMI) has received the most support in recent literature (42,43). This treatment is based 
on the observation of cortical abnormalities in CRPS, and is aimed at activation of cortical 
networks that represent the affected limb without actual limb movement. Various techniques are 
employed, such as:  hand laterality discrimination; imagined movements and the use of mirror box 
therapy (44). Mirror box therapy involves observing the movement of the reflected image of the 
unaffected limb in a mirror (45). Level II evidence exists that GMI is effective in reducing pain in 
adults with CRPS-1 and that the effect persists six months after treatment (42,43).  
 A recent systematic review on the use of PT for children with CRPS points out that the evidence 
to support PT in adults is of greater volume and higher methodological quality (19).  However, the 
authors still conclude that the current evidence in paediatric CRPS suggests that PT (when 
prescribed with other interventions) may lead to short-term improvement in signs and symptoms 
as well as improve function.  
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4.2.2 Psychological Therapy 
Various studies have refuted the once popular belief that people with underlying psychological 
problems or personality types may have a tendency to develop CRPS (46–50).  That being said, 
it is well established that suffering from a chronic pain condition has profound psychological impact 
and this should be addressed as part of the multidisciplinary treatment approach (1,25). For 
example, pain related fear (PRF) manifests itself in chronic pain conditions as a behavioural 
adaptation that leads to avoidance of use of the affected body area(51,52).  
A recent study by Simons et al., using functional MRI, demonstrated blunted activation in brain 
regions associated with emotional processing  in children suffering from CRPS(53). Bruehl et al., 
suggest a psychological treatment approach that includes education about the pathophysiology 
of CRPS, the negative effects of disuse and possible psychological/behavioural interactions (49). 
Children affected by CRPS are at an increased risk of developing depression and anxiety when 
compared to the general population (25). When compared to children with chronic back pain or 
headache, children with CRPS report greater functional disability and somatic symptoms, however 
overall psychological functioning appears to be similar between the groups, including similar 
scores on measurements of depression and anxiety (54). The importance of including 
psychological treatment as part of the multidisciplinary approach has been mentioned in various 
paediatric studies (30,32,46,55–57). Psychological therapies focus on teaching pain coping 
strategies and addressing pain-related beliefs and behaviours, relaxation therapy, assertiveness 
training and problem solving (24,42). In children with CRPS, family education becomes an integral 
part of the psychological treatment. In some instances admitting the child to hospital may be 
helpful in terms of disrupting underlying abnormal family dynamics (25). However, good results 
can also be achieved with an outpatient treatment approach including psychological and family 
treatment as part of the multidisciplinary team (58). 
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4.2.3 Other forms of treatment 
A multidisciplinary approach is the current  treatment recommendation in paediatric CRPS (25). 
Other forms of treatment mentioned in the literature with regards to treating paediatric CRPS 
include, but are not limited to, occupational therapy, recreational therapy, child life therapy, 
aromatherapy and acupuncture (12,30,32,57,58). In their review, Perez et al., concluded that 
occupational therapy may be beneficial in children with CRPS as part of the multidisciplinary 
approach (22,55). Recreational therapy may include activities like aquatic-, art-, music- and play 
therapy. By providing children with an opportunity to engage in preferred leisure activities, children 
may be more inclined  to use the affected limb (24). While the focused review by Katholi et al., 
suggests that acupuncture may be a safe and beneficial option in children, the risk would be 
further reduced if needleless techniques like electro-acupuncture were used (24).  
The exact role of adjunctive forms of treatments is difficult to establish since no studies 
investigating the efficacy of these modalities as stand-alone therapy could be found. 
4.3 Invasive treatments 
Various invasive treatments have been attempted as part of management in both adult and 
paediatric CRPS,  including but not limited to IV regional blocks, sympathetic nervous system 
blocks, sympathectomies, neuraxial blocks and spinal cord stimulation (38). In adult CRPS, two 
2013 Cochrane reviews concluded that the available data do not suggest that  local anaesthetic 
sympathetic block (LASB) is effective for reducing pain (38,41). In addition, one of the reviews by 
O’Connel et al., evaluated the evidence for a range of other interventions in CRPS and graded 
the quality of evidence too low for any conclusions to be drawn regarding these interventions 
(38,41). 
 Recently, two narrative reviews of the paediatric literature with regards to invasive treatments for 
CRPS have been published (23,56). In terms of frequency of use in children, single sympathetic 
blocks are currently most commonly used, followed by local anaesthetic infusion via epidural 
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catheters and continuous sympathetic blocks. Spinal cord stimulation, regional anaesthesia and 
pain-directed surgery are also used, but less frequently (56). Both reviews conclude that the 
evidence for invasive procedures in paediatric CRPS is weak (56,59). 
Good outcomes are often reported in studies employing invasive techniques, but the lack of 
control groups and validated outcome measures, limit the value of these results (56,59). Only one 
placebo controlled cross-over trial was found in children, testing the efficacy of lumbar sympathetic 
block with lidocaine, compared to IV lidocaine, and reported positive results with the lumbar block 
(60). However, treatment was part of a multidisciplinary treatment group and numbers were small, 
so the significance of the results is uncertain.  
 
Some paediatric studies are steering away from any medical or invasive therapy and follow a 
purely rehabilitative approach, discontinuing all medication and performing no invasive 
procedures. Many of these patients have had previous invasive procedures. These studies report 
satisfactory outcomes, although, as seen later in this review, the lack of a clear definition of 
satisfactory outcome limits the interpretability of results (12,55).  
In contrast, Rodriguez-Lopez et al. published a case series of 10 children in whom novel drugs 
(the 8% capsaican patch) and invasive techniques (epidural bupivacaine infusion for two weeks, 
followed by spinal cord stimulation if still symptomatic) were used in patients who failed to respond 
to a non-invasive treatment approach.  They reported a good response in terms of pain and 
function with these interventions (23). Similar to other studies on invasive treatments, 
interpretation of results is hampered by the fact that there is no randomisation, no control group 
and small patient numbers with a selection bias.  
Overall, current consensus in both adult and paediatric literature is that, since the evidence for 
invasive procedures is weak, these should be reserved for patients who fail to respond to non-
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invasive approaches, with the aim of treatment being to enable more effective participation in 
rehabilitation (28,37,38,41,56,59). 
5 Outcomes 
Long-term outcome from a chronic pain condition is of interest both to the health-care worker and 
to the patient as a means of judging treatment success. Outcome is defined in terms of pain and 
function, both of which affect quality of life. 
5.1 Pain 
Improvement in pain scores is one of the main goals of treatment. Most paediatric studies report 
high percentages of complete recovery but do not always specify whether pain resolution was 
specifically measured. Brooke et al., report complete pain resolution in 78% of patients in their 
study) (57).  Zernikow et al., used an 11-point numerical rating scale to measure pain. Their study 
reports an improvement in maximal pain score and average pain score from admission to follow-
up from 9.2 to 5 (45% improvement) and from 7.8 to 3.9 (50% improvement), respectively (12).Tan 
et al., conducted a longitudinal study on children with CRPS and reported that 52% of patients 
were still complaining of pain at a median follow-up of 12 years. Using a Visual Analogue Score 
(VAS), they report a mean pain score of 6.0 at admission, and of 4.5 at follow-up (constituting a 
25% improvement) (4).  Sherry et al., used a VAS of 0-100 for reporting pain, and report that 43 
out of 49 (88%) of patients were pain-free at a median follow-up of 5 years 3 months. Those with 
residual pain had a median score of 58 (55). Various studies don’t report the specific measurement 
tool used to assess pain or pain outcome, but may refer to patients as being symptom free or 
having fully recovered (30,40,61,62). This could potentially lead to bias since patients might not 
report pain if not specifically asked about it.  The time interval from admission to follow-up also 




5.2 Functional outcome 
In treating chronic pain conditions, it is recommended to steer away from a focus on pain 
resolution and focus instead on functional outcome as a measure of recovery. There are various 
challenges in establishing what the long-term outcome of paediatric CRPS is, including variation 
between studies in treatment regimes, length of time to follow-up and measures of functional 
outcome used. Follow-up intervals also vary widely, for example Murray et al., had a mean follow-
up of 6 months and Sherry et al., a mean follow-up of 5.3 years (55,61).  
Measurement of functional outcome also differs between studies. Both Kachko et al., and Sherry 
et al., used an evaluation at follow-up, which included pain scores, physical assessment of limb 
function and questions regarding school attendance and ability to take part in age-appropriate 
activities to assess functional status. The studies reported a 78.5% and 88% complete recovery 
rate respectively (55,62).  Zernikow et al., used the Paediatric Pain Disability Index (PPDI) and a 
Five-point scale of impairment in sport to assess outcome and reported a 50% average 
improvement in PPDI at follow-up and a 60% improvement of impairment in sporting performance 
(56).  
In the longitudinal study, Tan et al., used the Medical Outcome Study Short Form-36 (SF-36) to 
assess functional status. They report that CRPS patients scored lower than the general healthy 
population in two out of the eight domains assessed at long-term follow-up. From the findings the 
authors argue that childhood-onset CRPS does not have better outcomes than adult-onset CRPS 
(4), differing from other studies quoting a more favourable outcomes in children.  
6 Conclusion 
CRPS in children is a diagnostic and therapeutic challenge, with profound impact on the quality 
of life of those who are affected by it. There is currently no gold standard diagnostic test or 
standardised treatment regime, and both the exact incidence and long-term prognosis are 
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presently unclear. Diagnosis and treatment is often based on guidelines for adult CRPS and non-
CRPS neuropathic pain. 
Therapeutic options consist of various pharmacological agents as well as non-pharmacological 
treatment modalities like physiotherapy and psychological therapy. The success rate of treatment 
is uncertain in the literature due to poor standardisation of treatment modalities, therapeutic goals 
and outcome measurement tools. 
 There is a need for high quality studies in children with CRPS, including randomised controlled 
trials, but the low incidence leads to problems of sample size and there are ethical concerns with 
having control groups. Currently, case series studies add valuable knowledge regarding incidence 
and treatment outcomes of paediatric CRPS. New or unconventional treatment regimens should 
be reported to build data on possible therapeutic options. In performing this case series, we aim 
to contribute to the growing body of data regarding possible treatment options and outcomes in 
paediatric CRPS.  Additionally, we aim to determine whether CRPS in the setting of a developing 
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CHAPTER 2 PUBLICATION-READY MANUSCRIPT FOR SUBMISSION TO PEDIATRIC 
ANAESTHESIA 
For author guidelines of this journal, see Appendix B 
1 Introduction 
Complex regional pain syndrome (CRPS) is characterized by neuropathic-type pain, in a regional 
distribution, usually involving one of the limbs, but not limited to a specific dermatome. It may 
follow an injury, but can occur without any prior injury in about 10% of cases, and is characterised 
by continued pain that  is disproportionate to the inciting event (1). Distinction is made between 
CRPS Type 1 (CRPS I) and Type 2 (CRPS II), which refers to the absence or presence of 
demonstrated nerve injury, respectively (1). It is a diagnosis of exclusion and depends on reported 
symptoms and observed signs from four categories, including: sensory (i.e. allodynia, 
hyperalgesia), vasomotor (temperature or skin colour asymmetry), sudomotor (oedema or 
sweating) and motor/trophic changes (weakness, decreased ROM, hair, skin or nail changes) (1). 
The current recommended diagnostic criteria is the Budapest criteria of the International 
Association of the Study of Pain (IASP) (2). Although only validated for adults, it has been adopted 
for use in the paediatric population (3). 
The incidence of CRPS in children is unclear, but the largest pain centers in the USA and Europe 
reportedly treat 1-9 paediatric patients with CRPS per annum (4). The most effective treatment 
regime for paediatric CRPS is uncertain, and is mostly extrapolated from adult data or guidelines 
for non-CRPS neuropathic pain (5). Treatment usually consists of a multidisciplinary approach, 
with physiotherapy as the cornerstone, but can involve various forms of pharmacological 
treatments and invasive interventions (6,1). A higher quality of research is needed, but the low 
incidence of the disease poses a challenge, thus current paediatric data consists mainly of 
retrospective descriptive studies and case series (1). Long-term outcome data often does not 
report the time from treatment to follow-up or specify the outcome measures used (3).  
Furthermore, no case series in Africa could be identified in the literature search. 
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With this case series we aim to add to the growing body of data regarding paediatric CRPS. Pain 
and disease presentation can be socially and culturally influenced (7). Therefore, it is important to 
investigate whether children with CRPS in South Africa display a similar clinical course as children 
treated in other pain centers internationally. To facilitate comparisons we have used reproducible 
outcome measures and a minimum defined outcome period of 6 months or longer.  
2 Methods 
2.1 Recruitment 
For the purpose of the study, we collected and reviewed all the folders of children who were 
admitted to Red Cross War Memorial Children’s Hospital (RCWMCH), Cape Town, South Africa, 
with a diagnosis of CRPS Type I over a period of 5 years (1 June 2010 - 31 May 2015).  Approval 
for the study was obtained from the Hospital’s ethics committee as well as the University of Cape 
Town Faculty of Health Sciences Human Research Ethics Committee (Appendix C).  All patients 
and their parents or caregivers were contacted for telephonic consent before the folders were 
analyzed retrospectively (Appendix D and E). Information regarding symptoms and signs were 
obtained from the folder and subjected to the Budapest criteria to confirm a diagnosis of CRPS I 
(8).  
2.2 Retrospective folder review 
Socio-demographic history and clinical course until referral to RCWMCH was extracted from the 
folders. No specific standard of classifying severity of the initial injury that led to CRPS could be 
found in the literature. Therefore, we used the following criteria to define injury severity: none (no 
known injury), mild (bruise, sprain, or repetitive strain injury), moderate (fall from height or 
hairline/stress fracture on x-ray) and severe (fracture or surgery). The clinical course, treatment 
received, invasive procedures performed, total number of days spent in hospital and readmission 
rates were recorded for inpatient treatment.  
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Patients were admitted to the orthopedic ward, under the joint management of orthopedics and 
the RCWMCH pain management team. The pain management team consisted of an anesthetist-
directed, nurse-driven, multidisciplinary team, including physiotherapy, recreational therapy, 
aromatherapy and child life therapy by a therapist trained in child psychology. A psychiatric 
consultation was included if deemed necessary by the pain management team or requested by 
the patient or their family. Patients received daily intensive physiotherapy of between 2-4 hours. 
Modes of treatment included mobilization, graded motor imagery (including left-right 
discrimination, imaginary play, and in a few cases mirror box therapy) and graded exercise 
therapy(9). 
2.3 Long-term follow-up 
Long-term follow-up consisted of a telephonic interview and completion of questionnaires 
(Appendix F). Long-term was defined as a minimum of six months since admission to RCWMH.  
The Faces Pain Scale-Revised (FPS-R) was used to measure pain at follow-up (10)(Appendix G). 
This is a self-report measure, with possible values ranging from 0-10, using six animated faces 
representing varying expressions of pain and validated for use in children aged 4 and older (10).  
The Pediatric Quality of Life Inventory Version 4 (PedsQL 4.0) Generic Core Scales was used to 
assess Health Related Quality of Life (HRQOL). The scale includes Physical functioning (8 items), 
Emotional functioning (5 items), Social functioning (5 items) and School functioning (5 items). The 
participant was asked how much of a problem each item has been during the past month 
(Appendix H and I). A 5-point response scale was utilized (0=never a problem; 1=almost never a 
problem; 2=sometimes a problem; 3=often a problem; 4=almost always a problem). Items were 
reverse scored and linearly transformed to a 0–100 scale (0=100, 1=75, 2=50, 3=25, and 4=0), 
so that higher scores indicate better HRQOL. The mean was computed as the sum of the items 
divided by the number of items answered  (11). The scores from the study population as well as 
the change in scores over time, were compared to the normative data for healthy children and 
children with a chronic health condition, as defined by Varni et al, (11).  
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The telephonic interview included questions regarding full or partial recovery, time to symptom 
resolution, experience of a relapse and need for readmission, as well as any current treatment or 
medications taken related to CRPS pain (Appendix J). Time to Symptom resolution was defined 
as the time from admission to RCWMCH until being completely free of symptoms relating to 
CRPS. Partial recovery is described by Low et al., as persistent symptoms of CRPS, but a 
significant improvement in pain and ability to resume age-appropriate activities. A relapse is 
defined as recurrence of debilitating CRPS-related symptoms after being completely or near-
completely (having been able to resume age-appropriate activities) symptom-free for a period of 
at least three months. (12)  
3 Results  
3.1 Sociodemographic and medical history 
Ten children with a confirmed diagnosis of CRPS I were admitted to RCWMH pain centre over 
the study period. Nine patients were included since one patient could not be reached for telephonic 





Table 1: Sociodemographic characteristics of participants and nature of injury 
Age	 Gender	 Injury	 Site	 Medical	history	 Psychiatric	history	
Referral	
Base	
13	 male	 mild	 lower	limb	 none	 none	 Private	
9	 male	 mild	 lower	limb	 none	 none	 Private	





10	 female	 mild	 lower	limb	 none	 GAD,	ADD	 Private	
9	 female	 moderate	 lower	limb	 Asthma	 none	 Private	
14	 female	 none	 upper	limb	
Insulin	resistance,	
Iron	deficiency	 none	 Private	
12	 female	 moderate	 upper	limb	
Stargardt's	
disease	 none	 Private	
12	 female	 mild	 upper	limb	
Asthma,	Allergic	
Rhinitis	 none	 Private	






All children were referred from the private medical sector. Stressors such as financial strain in the 
family was mentioned in two cases; a recent death of a close family member in one case and 
bullying at school in another. 
 Three children had no previous medical history, while two had asthma and one had iron deficiency 
and insulin resistance. One child had abdominal surgery for pyloric stenosis as well as a diagnosis 
of “sensory defensiveness” as a small baby, and as an older child, developed Hashimoto’s 
thyroiditis as well as gastro-esophageal reflux disease. One child was diagnosed with Stargardt’s 
disease (macular degeneration) shortly after being diagnosed with CRPS and another had a 
history of extensive investigations for unexplained abdominal pain, as well as umbilical hernia 
surgery a month prior to the onset of their CRPS symptoms. Only one child had a specific 
psychiatric diagnosis prior to the onset of CRPS symptoms.  
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The diagnosis was of generalized anxiety disorder (GAD) and attention deficiency and 
hyperactivity disorder (ADHD), for which the child was on treatment with Escitalopram and 
Methylphenidate respectively.  
The time from initial injury to first seeking medical attention ranged from 1-30 days with a mean 
of 9.2 days (SD ± 9.1). The time from initial injury to referral to RCWMCH ranged from 2.5-27 
months with a mean of 7.5 months (SD ± 7.8). Positive findings on investigations were reported 
in two children. One showed a bone bruise and the other signs of possible peroneus brevis 
tendonitis on MRI. The average number of health care consultations that patients attended before 
referral to RCWMCH was 7 (range 5-10). The average number of medications taken at the time 
of admission was 2.4 (range 1-3). The investigations conducted, consultations sought and 




Table 2: Previous treatments, investigations and consultations prior to referral 
Treatment/Investigation/Consultation n=9 
Pharmacological treatments  
Acetaminophen 9 
Nonsteroidal anti-inflammatory drugs 9 
Tramadol hydrochloride 6 
Pregabalin 6 
Amitriptyline 5 
Oral steroids 2 
Antidepressant 2 
Non-pharmacological treatments  
Cast or splint of extremity 7 
Outpatient physical therapy 9 
Interventions  
Intra-articular steroid 1 
Brachial plexus block 1 
Femoral nerve block 1 
Investigations  
X-ray 9 
Magnetic Resonance Imaging(MRI) 8 
Blood Pathology 7 
Ultrasound 3 
Nerve Conduction 1 
Consultants   
Physiotherapist 9 
Orthopedic Specialist 9 
General Practitioner 9 
Alternative Health  8 
Physician/Rheumatologist 4 
Emergency Room Doctor 3 
Note that with regards to interventions, the numbers are non-overlapping, i.e. three different 
children each had one type of intervention.  
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3.2  Treatment at Red Cross War Memorial Children’s Hospital 
The average pain score on admission on the FPS-R was 8.7 (range 7-10, SD ± 0.97). The 
average number of investigations performed during admission at RCWMH was 0.5 (range 0-5, 
SD ±1.6), and no positive findings were reported. Eight children were admitted to hospital for an 
average number of 8.25 days (range 3-11, SD± 2.9). One patient was treated on an outpatient-
only basis. 
 Only one child underwent an invasive intervention in the form of an epidural catheter with a 
local anaesthetic infusion. The catheter was inserted under general anaesthesia with the aim 
being to facilitate participation in physiotherapy, since the child could not tolerate touch or 
movement of the affected limb.  The outcome of the intervention was poor. The child became 
severely distressed due to the decreased limb sensation and required sedation and removal of 
the epidural catheter. All the other children received non-invasive treatment only. See 




Table 3: Pharmacological Treatment in hospital 
Pharmacological Treatment  Dose Number of Children 
Gabapentin  15-35mg/kg/day 9 
Amitriptyline  10mg nocte  4 
Ketamine Intravenous Infusion 0.25-0.5mg/kg/hour for an average of 4.2 days 9 
Clonidine 5-14 mcg/kg/day 9 
Duloxetine 0.5-1mg/kg/day 2 
Tilidine (Opiate) Oral Drops 1mg/kg/dose prn  1 
Psychiatry was involved in the management of four of the patients. A fifth patient’s family, in whom 
it was felt would benefit, declined these services. Specific psychiatric diagnoses included: 
Adjustment disorder (two children), GAD and ADHD in one patient (known with these diagnoses 
prior to development of CRPS), and a query of possible Somatoform disorder and preoccupation 
with pain (one child), whose family did not attend outpatient follow-up with psychiatry after 
discharge. 
The average pain score on the Faces Pain Scale at discharge was 2.8 (range 0-8, SD ± 2.36). 
The average number of medications taken at the time of discharge was 2.5 (range 2-3, SD ± 0.52). 
These consisted of Gabapentin (nine patients), Clonidine (eight patients) and Amitriptyline (two 
patients), Duloxetine (one patient) or Fluoxetine (one patient) as well as Ibuprofen (nine patients) 
and Acetaminophen (nine patients) as needed. 
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3.3 Long term follow-up 
The time from admission until follow-up ranged from 6 to 21 months, with an average time to 
follow-up of 10.3 months after admission.  The average pain score at time of follow-up was 3.13 
(range 0 -8) (Figure 1).  
 
Figure 1. Pain score on admission vs. discharge vs. long-term follow-up 
(Note: Columns that are absent represent a pain score of 0) 
Of the nine children contacted for long-term follow-up, two (22.2%) were completely free of CRPS 
pain. The seven other children (78.8%) had residual symptoms of CRPS at the time of follow-up. 
Five children were still taking some form of medication for CRPS-related symptoms. The average 

























Commonly used medications were Gabapentin and Clonidine. Others included Pregabalin, 
Amitriptyline, Fluoxetine and Sertraline. 
Three children (33%) experienced a relapse of symptoms after having been free or nearly free of 
symptoms (able to resume age-appropriate activities) for longer than three months.  In two cases, 
the relapse was linked to having decreased medication and resuming recreational activities. In 
both of these cases, the CRPS flare-up was in the same limb as the original case and the pain 
was rated of similar intensity. Both these children were still experiencing CRPS pain at the time 
of follow-up and one had required re-admission due to the relapse. In the other child, the relapse 
occurred eight months after having been pain free, triggered by a new injury and in a different limb 
than the original CRPS. The relapse was less severe than the first time and the child made a 
complete recovery within six months without requiring admission. One child experienced a 
recurrence of symptoms after having been free of pain for just over one week. This was linked to 
an episode of emotional distress. This did not qualify as a relapse according to our criteria, since 
the child was not pain-free for a period of three months or longer. This flare-up of pain required 
the child to be readmitted. Two children (22.2%) required readmission to hospital during the time 
of our follow-up. 
Functional scores at long-term follow-up according to the PedsQL 4.0 are summarized in Figure 
2. Mean scores for the study population in the various functional domains are compared to the 
scores for a healthy study population and for children with other chronic health conditions as 
derived from the work from Varni et al,(11). 
 Varni et al, defined a minimal clinically important difference (MCID) as being the smallest 
difference in a score in the various domains of physical function that would be perceived by 
patients as being beneficial and that would mandate a change in the patient’s management. The 
MCID for PedsQL 4.0 scale scores was defined through calculating the Standard Error of 
Measurement (SEM), in which a change in score of one SEM represents a MCID. The value of 
the SEM for the respective functional domains are as follows: total score 4.36, physical function 
6.66, emotional function 8.94, social function 8.36 and school function 9.12(11) 
35 
At long-term follow-up children from our study scored similar to healthy children (less than one 
SEM difference) in all three psychosocial domains (emotional, social and school functioning).  In 
the domain of physical function, our study population’s quality of life score was significantly (more 
than one SEM) lower than both healthy children as well as children with other chronic conditions 
(average score of 63.54 vs 87.27 and 79.47 respectively, the SEM being 6.66). The total score 
for children from our study population was also significantly (more than one SEM) lower than their 
healthy peers, but not lower than children with other chronic health conditions.  ,  
Figure 2: PedsQL 4.0 Scores: Comparison of CRPS sample to healthy and chronic health 























Five children had the PedsQL 4.0 tool administered during admission at RCWMCH. For these 
children a comparison was made between functional scores at admission and at long-term follow-
up to determine change in HRQOL. As seen in Figure 3 all 5 children’s overall functional score 
had improved by equal to or more than the MCID at the time of follow-up, in other words every 
child had a clinically meaningful improvement in quality of life (Figure 3). 
  
 
Error bars on the admission column reflect SEM. Improvement by more than 1SEM is regarded as a MCID (see text) 
Figure 3: PedsQL 4.0 score comparison between admission and long-term follow-up across 




























4 Discussion  
The patients in our group demonstrated comparable socio-demographic characteristics as those 
reported in other paediatric studies (4,12–14). Similar to other studies, we noted the problems of 
delayed diagnosis, multiple consultations and investigations prior to referral and the use of 
invasive procedures prior to referral with poor treatment outcome(4,12,13). At the time of the 
study, all patients had been referred from the private medical sector. Possible reasons for this 
may have been established referral routes and awareness of the availability of treatment at 
RCWMCH.  
Children demonstrated a good response to an inpatient, multidisciplinary treatment approach in 
terms of pain, function and quality of life. This corresponds well to positive results reported in other 
studies with a similar multimodal treatment approach (4,12,15,14,16), and recommendation of 
recent reviews on the subject (1,17). Hospital admission may not always be feasible and the 
improvement of the one child, managed as an outpatient, correlates with studies that show good 
results of outpatient management (18). 
Our study showed an overall improvement in pain at discharge and follow-up as compared to 
admission. However, only two of the children (22%) had complete resolution of pain, markedly 
lower than reported elsewhere, for example a study by.  Brooke et al., reported complete pain 
resolution in 78% of 32 patients (14). These results may be influenced by the fact that 13 out of 
32 children in the study were lost to follow-up. They reported that at the time of discharge, 34% of 
children were free of pain. It is unclear how many of these children took part in the final follow-up. 
Another possibility is that their longer follow-up period (21 months, compared to 10.3 months) 
allowed more time for full recovery. Our results are more comparable to those of Zernikow et al., 
and Tan et al.(19,4) Zernikow et al., reported an improvement in mean pain score from 7.8 at 
admission, to 3.9 at follow-up (4). One possible reason for the comparable results is that their 
follow-up interval of 6.7 months more closely resembles ours of 10.3 months. Tan et al.,  reported 
that 52% of patients with childhood-onset CRPS still complained of pain after a median follow-up 
of 12 years (19). Possible reasons for the correlation with our results are that they had a fairly high 




Another possible reason for similarity is that they used a specific pain measurement tool, the VAS, 
where we used the Faces Pain Scale that also makes use of visual representation of pain 
symptoms(19).  Some studies do not specifically comment on pain outcome,  rather a report on 
resolution of symptoms or recovery(12,16). Since specific follow-up measures were often not 
reported, it raises the question whether patients were truly free of pain in these studies, or 
refrained from reporting it.  
The five children who had admission and follow-up data available for the PedsQL 4.0 
questionnaire demonstrated functional improvement over time following treatment. Total 
functional score for all five children improved more than the standard error of the mean (SEM), 
which is the Minimal Clinically Important Difference (MCID) as specified by Varni et al.(11). With 
regards to the whole sample group, children with CRPS demonstrated a lower overall HRQOL 
than their healthy peers at follow-up and scored similar to children with other chronic health 
conditions. The area worst affected was the physical domain, with functional scores approximately 
one Standard Deviation (SD) lower than other children with chronic health conditions and close to 
two SD lower than their healthy peers (11). This correlates with the findings of Logan et al., that 
children with CRPS report greater functional disability and somatic symptoms compared to 
children with other pain conditions, although demonstrating similar psychological functioning (20). 
Of interest, is that despite the significant physical challenges, children with CRPS demonstrated 
excellent school functioning at long-term follow-up, comparable to healthy peers and better than 
children with other chronic health conditions. This could be a demonstration of the theme in 
literature that children with CRPS are often “high achievers” with strong personal drive and a 
tendency to be compliant  (21,20).  
Only two out of nine (22%) children had achieved complete recovery according to our definition 
(pain-free and having assumed age-appropriate activities), which is lower than the recovery rate 
reported in other studies. Low et al., reported complete resolution in  92% of 13 children and 
Kachko et al., in 78.5% of 14 children (12,16).The differences in reported recovery rates may be 
a consequence of unclear definitions of recovery in the literature and invalidated tools being used 
to assess outcome. Zernikow et al., reported a 50% improvement in function at long-term follow-
up, using the validated Paediatric Pain Disability Index, a result which more closely resembles the 
approach employed in this study (4).  
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Three children in our study (33%) experienced a relapse, comparing well to relapse rates reported 
in other studies (22% to 37%) (12,22,14,16)  
We believe key elements in the success of treatment are the emphasis on intensive 
physiotherapy, with all other forms of treatment, including medication, psychological treatment 
and invasive interventions focused on enabling participation in physiotherapy. This corresponds 
well to other studies, which report a good outcome with conservative treatment emphasising 
physiotherapy (4,12,14,16). Physiotherapy should be aimed at mobilising and graded exposure, 
including graded motor imagery as a tool for treatment (23).   
Informal conversation with caregivers highlighted that they found the support of the pain 
management team during admission and after discharge from hospital very beneficial. This was 
not formally assessed by us in our cohort, but is in agreement with other paediatric studies 
reporting support to be a crucial component of treatment (12,14,16). Important focus points 
contributing to the team’s ability to provide support include teaching of pain management together 
with coping skills, behavioural and cognitive interventions delivered by all members of the pain 
management team. These include assistance in verbalisation of feelings, self-awareness and 
assertiveness. Family education and support also plays an integral role in treatment success 
(1,12).  
Ketamine infusion at sub-anaesthetic dosages was used with good success in our series, reducing 
pain scores and enabling participation in physiotherapy, with minimal side effects reported. This 
is in agreement with recent paediatric literature, which reported an improvement in CRPS pain 
with sub-anaesthetic intravenous ketamine infusion (24). In our experience a longer duration of 
infusion was more beneficial than a shorter one, with our current aim being a minimum of three 
days, but ideally five days if tolerated.  
The one child in our study that underwent an invasive procedure in the form of an epidural local 
anaesthetic infusion had a poor response. In line with current recommendations, our current 
treatment approach is to use invasive treatment options once non-invasive treatment has failed, 
and then only with the aim of supporting participation in physiotherapy (17,25).  
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Limitations of our study include the small number of patients, the retrospective nature of a case 
series, and the fact that there is no control group. The diagnosis was retrospectively confirmed by 
applying the Budapest Criteria to symptoms and signs recorded in the file. It is possible that some 
symptoms and signs were not asked about and therefore were not recorded. The PedsQL 4.0 tool 
was not consistently administered during admission, which hampered assessment of change in 
functional status over time. The normative data used for interpretation of functional outcome was 
obtained from a population different to our own. Normative data of the local population may be 
different, which could affect interpretation of results. At follow-up, patients were asked if they had 
ever been free from CRPS pain, but symptoms and signs were not objectively assessed using the 
Budapest Criteria. This could lead to patients reporting pain other than true CRPS symptoms and 
could affect the outcome data.  
5 Conclusion 
CRPS I in children can be effectively treated with a non-invasive multidisciplinary treatment 
approach, with an emphasis on physiotherapy, psychological support and family education. Often 
an inpatient treatment approach is required but good results are achievable in suitable outpatient 
candidates. In our study, intravenous ketamine at sub-anaesthetic doses was used with good 
effect to decrease pain and enable participation in physiotherapy. Overall, children demonstrated 
significant improvement in pain and good recovery of emotional, social and school functioning, 
despite having a lower physical functional status than other children with chronic health conditions. 
There is a need for clear definitions of treatment success and expectations, which should be 
discussed and agreed upon between the clinician, patient and the patient’s family.  Specifically, 
repeatable outcome measures of pain and function should be used to enable assessment of 
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Appendix A: Budapest Criteria  
For a diagnosis of CRPS A-D must apply. 
A) The patient has continuing pain which is disproportionate to any inciting event 
B) The patient has at least one sign in two or more of the categories 
C) The patient reports at least one symptom in three or more categories 
D) No other diagnosis can better explain the signs and symptoms 
Category Explanation Sign (you can see or 
feel a problem) 
Symptom ( the patient 
reports a problem) 
1. Sensory Allodynia( to light touch and/or 
temperature sensation and/or 
deep somatic pressure and/or 
joint movement) and/or 
Hyperalgesia (to pinprick) 
 Hyperesthesia does 
also qualify as a 
symptom 
2. Vasomotor Temperature asymmetry and/or 
skin colour changes and/or skin 
colour asymmetry 
If you notice 
temperature 





Oedema and/or sweating 





Decreased range of motion 
and/or motor dysfunction 
(weakness, tremor, dystonia, 
and/or trophic changes 
hair/nail/skin) 
  
Reference: Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic 
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conventions, e.g. 'figure1.tif'. Space in the print version is limited. Please consider if any of your figures (or tables) could 
appear online only as Supplementary Data. Additional figures and tables can be made available on the web version of 
the journal. 
Requirements 
Photographs - 300 dpi TIFF files at desired print size. A single column image would need to be 300dpi and 120mm 
wide. A full page image would need to be 300dpi and 230mm wide. 
Line work - EPS is preferred as this is vector based software and allows smaller file sizes. The figure size requirements 
still apply - 120mm wide for a single column; 230mm wide for a whole page image. 
Most graphic software can output to EPS via a 'print to' PS or PDF printer. If this is not possible, then we can accept high 
resolution tiff files - 600dpi at single column/ whole page widths. Lower resolutions will cause the text / line element to 
break up. 
Lines should not be thinner than 0.25 pt and in-fill patterns and screens should have a density of at least 10%. Use 10pt 
Helvetica font for labels. 
Combination images (figures with both linework or text and photographic elements) - EPS is preferred. The 




Audio/ Video recordings 
The recording must be continuous and of sufficient quality for us to publish online i.e. no shaking, blurring or 
interference. 
The file must be saved in .mov format for video and MPEG, MP3 or MP4 format for audio. 
The recording should last no longer than 10 minutes. 
The file must be less than 2GB in size. 
The resolution should be 1280 x 720 (16 x 9 HD) or 640 x 480 (4:3 SD), if possible. 
Supporting Data 
We do not publish appendices. Supporting material that is too lengthy for inclusion in the full text of the manuscript, but 
would nevertheless benefit the reader, can be hosted as online-only content, linked to the online manuscript. The 
material should not be essential to understanding the conclusions of the paper, but should contain data that is additional 
or complementary and directly relevant to the article content. Such information might include the study protocols, more 
detailed methods, extended data sets/data analysis, or additional figures (including colour). 
All material to be considered as supporting data must be uploaded separately as such with the manuscript files during 
submission. It cannot be altered or replaced after the paper has been accepted for publication. Please indicate clearly 
the material intended as Supplementary Data upon submission. Also ensure that the Supplementary Data is referred to 
in the main manuscript. Please label these supplementary figures/tables as S1, S2, S3, etc. Full details on how to submit 
supporting data, can be found at http://authorservices.wiley.com/bauthor/suppinfo.asp 
Permission to include other’s work 
Permission to reproduce material within the manuscript must be obtained in advance by the corresponding author. Refer 
to the organisation responsible for managing the rights of the original author. Expect this to take up to six weeks. Once 
granted, upload a copy of the approval as a supporting file. Full attribution to the source must be made in the figure 
caption. 
SUBMISSION REQUIREMENTS 
All submissions to Pediatric Anesthesia should conform to the uniform	requirements for manuscripts submitted to 





All submissions should include the following: 
Main document 
1. TITLE PAGE 
2. Title and running head (short title); 
3. Article category; 
4. First name, middle initial (if any) and family name of all authors – no degree/titles/ positions of responsibility. All 
those listed as authors must fulfill the ICMJE criteria – see above; 
5. Affiliations should be written after the authors list as follows and linked to authors with corresponding superscript 
number. Only include: Department, division or unit name in English, (if any), affiliation name, city(without state), 
country; 
6. Corresponding author details should be written after the affiliations list as follows: title (Mr/Mrs/Ms/Dr/Prof), first 
name(s) written with initials only, and followed by the last name – e.g. Dr. J. E. Smith; add Department, division or 
unit name in English, (if any), affiliation name, street address, city, postal code, country. Email address; 
7. For research reports only, add 1-2 sentences answering the following questions in bullet points: 
a. What is already known 
b. What this article adds 
8. A structured abstract for research reports with a clearly stated background, aim, method, results and conclusion; 
9. A summary for educational reviews, systematic reviews special interest articles and case reports 
10. Six MeSH-compliant keywords (http://www.nlm.nih.gov/mesh) that do not replicate the title 
11. Disclosures: Indicate at the end of the text before references: 1. Any necessary ethical approval(s); 2. The source 
of funding for the study with grant numbers; and 3. Any conflict of interest. You are required to make a statement, 
even if the answer is ‘none’. 
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12. A reference list in Vancouver style (number/author) endnotes in the order made in the text. Example: confirmed by 
other studies.23 / 23 Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535. For books, names and initials of all authors, the 
full title, place of publication, publisher, year of publication and page number should be given. 
13. Tables – if any, in tabulate text at the end of the main document, following the references. DO NOT submit tables 
as separate files. Tables submitted as pictures cannot be used. 
14. Figure captions – if any, in a list following the references/ tables. (Figures must be uploaded additionally as 
individual graphic files. Please do not embed figures.) Figures embedded in word cannot be used by the publisher. 
Figures should be submitted as single separate image files: either resolution independent EPS files, or high 
resolution (600dpi at print size) TIFF files. 
Supporting information/additional files if appropriate 
1. Figures – prepared and labelled as advised in ‘PRE-SUBMISSION ADVICE AND PREPARATION’ above. 
2. Audio/ Video - prepared as advised in ‘PRE-SUBMISSION ADVICE AND PREPARATION’ above. Please use the file 
designation 'audio/video data'. 
3. Supplementary data - prepared and labelled as advised in ‘PRE-SUBMISSION ADVICE AND PREPARATION’ above. 
Please use the file designation 'supporting data'. 
4. Study protocol – the appropriate study protocol (see ‘Guidelines on specific papers’ below) 
5. Consent for publication– A completed / signed parental/patient consent form should be uploaded onto S1M as file 
designation 'Publication consent'. Download the links given in ‘POLICIES’, above. 
6. Online video broadcast release – a completed form should be uploaded onto S1M as file designation 'online 
broadcast release'. Download the links given in ‘POLICIES’, above. 
7. Permission – if reproducing others work (see ‘PRE-SUBMISSION ADVICE’ above). 
Accepted article types 
Research reports – Research reports should follow the "Minimal standards for reporting in Pediatric Anesthesia". 
Clinical Implications, please add 1-2 sentences answering the following questions: 
a. What is already known about the topic 
b. What new information this study adds 
A structured abstract of no more than 300 words should include the following: Background; Aims; Methods; Results; 
Conclusions. 
Maximum words – 3500; maximum figures and tables – 6; maximum references – 25. Word counts include all text from 
the introduction to the end of the text after the disclosures. 
 
Educational Reviews - Educational reviews should have the following structure: Introduction, Main Article, Summary, 
Reflective questions, References. Present 3-4 reflective questions that the reader should ponder upon when they have 
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assimilated the knowledge within the article. 
Summary of no more than 300 words. 
Maximum words – 5000-6000; maximum references – 20. Word counts include all text and references. 
 
Systematic reviews – Systematic reviews are encouraged and should include a clear aim and search strategy. If the 
review is a meta-analysis it should be submitted and structured as a research report with an abstract, background 
methods, results discussion, and a clearly articulated aim, search strategy etc. 
Summary of no more than 300 words giving information on methods of selecting the publications cited. 
Maximum words – 4000; maximum figures and tables – 6; maximum references – no limit. Word counts include all text 
from the introduction to the end of the text after the disclosures. 
 
Special interest articles – Novel papers that are neither research reports nor reviews on specific topics will be 
considered if they have a great and broad interest to the specialty. 
Summary of no more than 300 words. 
Maximum words – 4000; maximum figures and tables – 6; maximum references – no limit. Word counts include all text 
from the introduction to the end of the text after the disclosures. 
 
Case reports – only exceptional reports that have important education or safety messages will be considered. Our 
current rejection rate is 90%. Conclude with 3 learning points for our readers. All case reports require parental/ patient 
consent for publication. 
Summary of no more than 100 words. 
Maximum words – 1000; maximum figures or tables – 1; maximum references – 5 Word counts include all text and 
references. 
 
Editorials - Editorials are usually by invitation. They should be less than 1500 words and should refer to a paper in the 
issue within the first two sentences. They should have less than 6 references and no tables or figures. Usually they 
should have 3 or fewer authors. 
 
Correspondence – Letters to the editor are encouraged, particularly if they comment, question or criticize research 
reports that have been published in the journal. Such letters MUST refer to the research reports in the first paragraph, 
and list that paper as reference 1. 
Letters that describe cases are only considered if they have an important safety message and require parental/ patient 
consent for publication. 
Maximum words – 800; maximum figures and tables – 1; maximum references – 5. 
Word counts include all text and references. 
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Guidelines for specific papers 
Randomised clinical trials (RCTs) must conform to the CONSORT statement (http://www.consort-statement.org) on 
the reporting of RCTs. A flow diagram of subjects, the trial protocol, and the registration details of the trial must be 
included in the paper, along with and a numbered checklist provided as supplementary material. 
Diagnostic studies must conform to the STARD statement http://www.stard-statement.org/.  A flow diagram of subjects, 
the trial protocol, and the registration details of the trial must be included in the paper along with and a checklist provided 
as supplementary material. 
Qualitative research – aauthors should refer to the EQUATOR NETWORK resource guidance on good research 
reporting (http://www.equator-network.org), which has the full suite of reportingguidelines (both quantitative and 
qualitative). 
 
Observational studies (Epidemiology): Please follow the STROBE guidelines http:// www.strobe-statement.org/ and 
submit the study protocol as supplementary material. 
Systematic reviews/ meta-analysis of randomised trials and other evaluation studies must conform to PRISMA 
guidelines http://www.prisma-statement.org (these have superseded the QUOROM guidelines) and submit the study 
protocol as supplementary material. 
SUBMISSION  
Submissions must have been read and approved by all authors. Submission of a manuscript implies that it reports 
unpublished work and that it is not under active consideration for publication elsewhere, nor been accepted for 
publication, nor been published in full or in part (except in abstract form). 
All material to be considered for publication in Pediatric Anesthesia should be submitted via the journal's online 
submission system at Scholar One Manuscriptshttp://mc.manuscriptcentral.com/pan. 
Full instructions and support are available on the site and a user ID and password can be obtained on the first visit. If 
you have any queries please contact Lou Whelan, Pediatric Anesthesia Editorial Office: paneditorialoffice@gmail.com 
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Once you are ready to submit, check: 
Your main document conforms to our requirements; 
Figures are uploaded as graphic files; 
Supporting documents are uploaded and designated correctly; and 
You have completed all submission steps  –  ensure the DISCLOSURE section (step 5) is correct. 




If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email 
prompting them to login into Author Services; where via the Wiley Author Licensing Service(WALS) they will be able to 
complete the license agreement on behalf of all authors on the paper. 
For authors signing the copyright transfer agreement If the OnlineOpen option is not selected the corresponding 
author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can 
be previewed in the samples associated with the Copyright FAQs below: 
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp 
For authors choosing OnlineOpen If the OnlineOpen option is selected the corresponding author will have a choice of 
the following Creative Commons License Open Access Agreements (OAA): 
Creative Commons Attribution License OAA 
Creative Commons Attribution Non-Commercial License OAA 
Creative Commons Attribution Non-Commercial -NoDerivs License OAA 
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley 




If you select the OnlineOpen option and your research is funded by certain funders [e.g. The Wellcome Trust and 
members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to 
publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK 
requirements. For more information on this policy and the Journal’s compliant self-archiving policy please 
visit:http://www.wiley.com/go/funderstatement. 
Colour 
Journal policy states authors pay the full cost for the reproduction of their colour artwork. On acceptance of your paper 
for publication, if you would like for your figures to appear in colour complete and sign the Colour Work Agreement 
Form (CWAF). This form is available via http://mc.manuscriptcentral.com/pan or  SN_Sub2000_P_CoW.pdf	
Once completed, please return the form to Customer Service at the following address: 
Customer Services (OPI) 
John Wiley & Sons Ltd 
European Distribution Centre 






Proofs will be sent to the corresponding author and should be returned within 48 hours of receipt to avoid delay in 
publication. Overseas contributors should ensure that a rapid airmail service is used. Authors are encouraged to use E-
annotation tools available in Adobe Acrobat Professional or Acrobat Reader (version 7.0 or above) to e-annotate the 
PDF copy of their proofs, which can be returned electronically. 
AUTHOR BENEFITS  
Open Access Publishing 
OnlineOpen is available to authors of primary research articles who wish to make their article available openly on 
57 
 
publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the 
author, the author's funding agency, or the author's institution pays a fee to ensure that the article is openly 
available  upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For 
the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms. 
 
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our 
website at https://authorservices.wiley.com/bauthor/onlineopen_order.asp. 
 
Prior to acceptance, there is no requirement to inform the Editorial Office that you intend to publish your paper 
OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go 
through the journal's standard peer-review process and will be accepted or rejected based on their own merit. 
 
Early View 
Pediatric Anesthesia has an Early View service. Early View articles are complete full-text articles published online in 
advance of their publication. Articles are therefore available as soon as they are ready, rather than having to wait for the 
next scheduled issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for 
publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can 
be made after Early View publication. The nature of Early View articles means that they do not yet have volume, issue or 
page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object 
Identifier (DOI), which, if cited with the journal name and year of publication. allows the article to be cited and tracked 
before it is allocated to an issue. After publication, the DOI remains valid and can continue to be used to cite and access 
the article. 
Author Services 
Online production tracking is available for your article through  Author Services. 
Author Services enables authors to track their article - once it has been accepted - through the production process to 
publication online and in print. Authors can check the status of their articles online and choose to receive automated e-
mails at key stages of production so they don’t need to contact the production editor to check on progress. 
Visit http://authorservices.wiley.com/bauthor/for more details on online production tracking and for a wealth of resources 
including FAQs and tips on article preparation, submission and more. 
Free access to the final PDF offprint of your article will be available only via Author Services. Please therefore 





Additional paper offprints may be ordered online. Please click on the following link, fill in the necessary details and 
ensure that you type information in all of the required fields:Offprint.Cosprinters . If you have queries about offprints 
please email offprint@cosprinters.com. 
Back issues 
Single issues from current and recent volumes are available at the current single issue price from cs-
journals@wiley.com. Earlier issues may be obtained from the Periodicals Service Company, 11 Main Street, 
Germantown, NY 12526, USA. Email: psc@periodicals.com 
Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, we 
will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your 
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Appendix E: Telephonic Interview Script: Parent Consent 
Good day, is this Mr/Mrs/Ms (Name)? 
My name is Mariesa Nock; I am a medical doctor at Groote Schuur Hospital and I am specialising 
in Anaesthesia through the University of Cape Town. I am conducting a research study at Red 
Cross War Memorial Hospital involving children who were admitted and treated for the diagnosis 
of Complex Regional Pain Syndrome over the last few years.  The purpose of the study is to look 
at the treatment the hospital currently provides and determine what the long-term outcomes are 
of the children who suffer from this condition.  
The study has two parts:  
Firstly, with your consent,  I will access your child’s folder and collect information from it.  This 
information will include things like age, nature of initial injury, investigations and treatment 
received prior to admission to hospital and also what treatment was received during admission to 
Red Cross War Memorial Hospital.  
Secondly, I would like to evaluate how your child is doing at the moment. To do this I would like 
to evaluate their pain severity, and how their pain interferes with their daily activities using two 
questionnaires. The one is called the Faces Pain Scale-revised which will ask your child to point 
at a picture of the face which best represents their pain at present. The second questionnaire is 
the Paediatric Quality of Life Inventory, which both you and your child will need to complete. This 
questionnaire asks how much of a problem your child’s pain has been to them in different areas 
of ordinary life.   It will take approximately 10 minutes to complete. Both these questionnaires were 




 The risks to your child are that talking about the subject might be distressing to him/her or that 
thinking about it and talking about it might cause a flare up of pain. If this occurs I will refer you to 
the necessary health care provider.   
Everything we discuss will be kept strictly confidential, for all recording purposes we will be using 
only your child’s folder number and their name will not be included in any of the information.  
His/her folder will also be kept in a safe location so that no one else but me will have access to it. 
If the findings of the study are published in a medical journal, the identity of your child will remain 
anonymous.  
There is no specific benefit to you or your child by taking part in the study. We hope that the study 
will increase our understanding of CRPS and the outcomes we achieve with our treatment so that 
we can continue to improve the care we give to other children who suffer from CRPS.  
If during the completion of the questionnaire I realise that your child still has a lot of pain that is 
significantly interfering with their life, I will recommend that you see your local healthcare provider 
and if you give permission I will provide a referral letter to them.  The medical costs of this will be 
for your own account.   
If you do not want to take part you don’t have to. If at any point you want to stop taking part or you 
don’t want to answer a question, you can inform me and we shall stop the interview. Whether you 
choose to participate or not will not affect your child’s management at RCWMH in any way now 
or in the future. You will not receive any payment for participating in the study.  
Do you have any questions? 
Would you be willing to participate in this study? 
If they say no: thank you for your time, have a good day. Bye. 
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If they say yes – continue: I would also like to make sure (Your child’s name) is happy to take 
part in the study; can you please ask them to come to the phone? Or indicate a convenient time 
to speak to your child if you would like to speak with them first? 
If (your child) is also happy to take part, I would like to set up an appointment date when I can 
phone you again to complete the questionnaires. I will be sending you a copy of the 
questionnaires, so you can have a copy in front of you while I ask the questions over the phone. 
How do you prefer me to send the questionnaires to you?  
(Record email or postal address…..) 
When would be a convenient time for me to phone you again for completion of the questionnaires? 
(Record date and time…..) 
 
Please record the following contact details in case you need to get hold of me for any reason… 
(Provide parent with my name and contact telephone number..) 
Please also take down the number for the University of Cape Town’s Ethics Committee if you 
have any questions with regards to your child’s rights and welfare in taking part in research. 
(UCT FHS Research Ethic Committee Tel 021 4066338) 
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Appendix F: Telephone script for Child Assent 
Good day is this (Child’s name)? 
My name is Mariesa Nock; I am doctor from Red Cross Hospital in Cape Town. 
Do you remember the time when you came to Red Cross with your mom and dad because of the 
pain in your (leg/arm)? (Make sure the child remembers the time and admission that I am referring 
to). 
Do you remember the name the doctors gave the pain in your (leg/arm)?  The name they gave it 
is CRPS, which is a short name for Complex Regional Pain Syndrome.  
This type of pain is very rare, that means not many children will ever have the type of pain you 
had. It also means that when doctors see children with this kind of pain they do not always know 
what it is or how to make it better.   
There have been just a few other children who came to Red Cross hospital because of the same 
type of pain that you had. I am phoning you and all these other children to ask for help with 
research.  
 Research is something we do to find out about the way things work. We use research studies to 
better understand an illness and find better ways of helping and treating children who are sick.  
I want to find out whether your visit to Red Cross helped you get better. This will help doctors in 
the future to know what to do when other children with pain because of CRPS come to us for help.  
To find this out I will be doing two things:  
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Firstly, I will look at your hospital file and read the notes that the doctors made while you were 
here. I will make my own notes from this, like how old you are, how you got hurt, what medicine 
and treatments (like visits to the Physiotherapist) you tried before coming to Red Cross. I will also 
write down what the doctors, nurses and physiotherapists did to help you get better while you 
were at Red Cross.  
Secondly, I want to find out how you are doing now. For this I will ask you a few questions over 
the phone about whether you still have pain and if you do still have pain, how much of a problem 
the pain is in your daily life. It will take about 10 minutes to complete the questions.  
Sometimes people worry that something bad might happen to them if they are asked to take part 
in research. One possible “bad thing” that can happen is that you might find it hard to talk about  
the pain and perhaps that talking about it and thinking about it, may make the pain get worse 
again.  If this does happen, I will make sure you get the help you need.   
You may worry that other people may find out who you are and about your visit to Red Cross by 
saying yes to helping me with the research. I will make sure that no one else but I look at your 
hospital file and when I write down notes I will not use your name anywhere so no one will know 
who I am talking about.  
If you do not want to take part you don’t have to. Even if you say yes now, you can still change 
your mind later and tell me that you want to stop and I won’t be upset or angry. Whether you 
choose to take part or not will not change how people treat you if you ever have to come to Red 
Cross Hospital again. You and your parents will not get any money for helping me with the 
research. Your parents or the person responsible for taking care of you will also have to agree 
that you can take part in the study before we can go ahead.  
Do you have any questions you would like to ask me? 
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I will give your mom/dad my telephone number, so if you think of any questions later, please call 
and I will be happy to explain.  
Would you be willing to let me look at your hospital file and for me to phone you again at a different 
time to ask you some questions? 





Appendix G: Script for Telephonic follow-up interview 
Hi there, is this Mr/Mrs X? 
This is Mariesa Nock, the doctor from Red Cross Hospital that phoned you a while ago regarding 
the research study I am doing about children who were treated at Red Cross Hospital for Complex 
Regional Pain Syndrome. Do you remember? 
If no: Explain again (revert to precious telephonic script)  
If yes: Continue… 
Are you and (child’s name) still happy for me to ask you both a few questions? Do you have any 
questions you would first like to ask me?  
If still happy and once all questions answered, proceed… 
Is now a good time for you both or would you like to reschedule? 
Reschedule or continue… 
Did you receive the questionnaires that I sent you? 
If no: Get details to resend and make new appointment for follow-up 
If yes: Continue...  
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Do you have the questionnaires in front of you so you can look at them while I ask you the 
questions?  (Give them time to get hold of the questionnaires.) 
First I would like to start with the questionnaire with all the pictures of faces on it. Can you please 
have it ready for (child’s name) to look at and then put (him/her) on the phone? After that I will be 
doing the questionnaire called “PedQL Child Report”, please have that ready for him/her as well.  
Administer Modified Brief Pain Inventory 
Throughout our lives, most of us have had pain from time to time (such as minor headaches, 
sprains and toothaches). Have you had pain other than these everyday kinds of pain today?  
Yes _____continue on to Faces Pain Scale, if No _____Omit Faces Pain Scale 
Administer Faces Pain Scale 
Look at the faces on the paper in front of you. The face on the far left side marked as number 1 
shows no pain. The faces show more and more pain, up to the one on the far right, marked as 
number 6, which shows very much pain. Please point to the face that shows how much you hurt 
(right now). Can you (or your mom/dad) tell me the number of the face that you are pointing to?  
Administer PedsQL 4.0 Child 
Read through the introduction and questions of PedsQL child version and record answers 
Thank you very much for helping me by answering these questions. Please can you put your 
mom/dad back on the phone for me? 
69 
 
Hi Mr/Mrs X, thank you for assisting (child’s name) with completing the questions.  
Do you have the Questionnaire named PedsQL Parent proxy-report in front of you?  
Administer PedsQL 4.0 parent proxy-report  
Follow the lay-out of the questionnaire and record the answers 
Thank you very much for your help in answering those questions. I have just three more questions 
and then we are done.  
Is (child’s name) taking any medication for pain at the moment? 
Record names of pain medicine, frequency and dosage 
Is (child’s name) taking any other types of medicine at the moment?  
Record names of medicine and dosage 
Has (child’s name) been admitted to hospital again for the symptoms of CRPS since he/she was 




Appendix H:  Faces Pain Scale-Revised 
Note that the faces on the questionnaire are upside-down because the instrument is designed to 
be printed and then folded along that dotted line so the child points to a face and the clinician 
records a number. I will just be sending a paper copy of the faces to the child and will be reading 
the instructions verbally. Example of upright faces also provided below. The faces will be given a 












































Appendix K: CRPS long-term outcome questionnaire  
Your name: __________________________ 
Today’s date: _________________________ 
Please tick next to the most appropriate answer and expand in your own words where 
necessary 
1. Were you free of your CRPS pain at the time that you were discharged from Red Cross 
Hospital? Yes____________ (Continue to Question 4) No_____________ (Continue 
to Question 2)  
2. If no, have you ever been completely free from your CRPS pain since leaving Red 
Cross Hospital? Yes________________(Continue to Q3)No_______________ 
(Continue to Q 8) 




4. Did the symptoms of your CRPS ever return after you became pain free?                                   
     Yes, it returned_________ When did this 
happen?____________________( Continue to Q5) 
 No, the symptoms never returned_______________________________ (if no, 
Continue to Q8) 
5. What do you think triggered the return of your CRPS symptoms? An 
injury_______________ Stopping medication________ 
Other____________________________________________ 
6. In which part of your body did the symptoms return? Same limb as initial 




7. How would you rate the symptoms of the relapse compared to your first episode of 
CRPS?               Not as bad as the first time _____________ Similar to the first 
time_______________________ More severe than the first 
time________________________ 
8. Were you ever re-admitted to hospital for your CRPS symptoms? 
Yes_________No___________ 
9. Are you currently still taking any medication for CRPS-related pain? Yes_____No___ 
10. If yes, please give names of 
medication________________________________________________________ 
11. Are you currently still undergoing any physiotherapy treatment for your CRPS 
symptoms? Yes____________ No_____________ 
12. Are you currently receiving any other form of treatment for help with your CRPS 
symptoms?  Yes_________ No___________ 
13. If yes, please 
specify____________________________________________________________ 




Please return the completed questionnaire to: mariesa.schutte@gmail.com 
Please phone if you have any queries: Tel 0764020864 
Dr Mariesa Nock,  
Department of Anaesthesia, Groote Schuur Hospital and Red Cross War memorial 
Hospital 
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